dc.contributor.author |
Lopez, C. E. |
|
dc.contributor.author |
Mosquera, S. |
|
dc.contributor.author |
Taype-Rondan, A. |
|
dc.date.accessioned |
2019-01-25T17:02:40Z |
|
dc.date.available |
2019-01-25T17:02:40Z |
|
dc.date.issued |
2017 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/4973 |
|
dc.description.abstract |
Direct-to-consumer advertising (DTCA) of pharmaceuticals is undertaken by pharmaceutical companies in order to encourage the consumption of medications. The US Food and Drug Administration (FDA) classifies DTCA into three types: (1) reminder advertisements contain the name of a drug only and are designed to reinforce brand recognition; (2) help-seeking advertisements contain information about a disease or condition without mentioning a particular treatment; (3) product-claim advertisements contain specifically effective and safe information about drug products and display ads that contain the names of them, indications, and information about their safety and effectiveness... |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
BMJ Publishing Group |
|
dc.relation.ispartofseries |
European Journal of Hospital Pharmacy |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Pharmacology & Pharmacy |
en_US |
dc.title |
Direct to consumer advertising on websites of Peruvian naturopathic pharmacies |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1136/ejhpharm-2016-000897 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.01.05 |
|
dc.relation.issn |
2047-9964 |
|